These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 6314397)

  • 1. The effects of SKF 525-A on the analgesic and barbiturate-potentiating activity of delta 9-tetrahydrocannabinol in mice and rats.
    Sofia RD; Barry H
    Pharmacology; 1983; 27(4):223-36. PubMed ID: 6314397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of anandamide- and fluoroanandamide-induced antinociception and cross-tolerance to delta 9-THC after intrathecal administration to mice: blockade of delta 9-THC-induced antinociception.
    Welch SP; Dunlow LD; Patrick GS; Razdan RK
    J Pharmacol Exp Ther; 1995 Jun; 273(3):1235-44. PubMed ID: 7791096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of various psychoative drugs on the metabolism of delta-tetrahydrocannabinol by rats in vitro and in vivo.
    Siemens AJ; De Nie LC; Kalant H; Khanna JM
    Eur J Pharmacol; 1975 Mar; 31(1):136-47. PubMed ID: 1126372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro metabolic formation of a new metabolite, 6 beta-hydroxymethyl-delta 9-tetrahydrocannabinol from cannabidiol through an epoxide intermediate and its pharmacological effects on mice.
    Nagai K; Watanabe K; Narimatsu S; Gohda H; Matsunaga T; Yamamoto I; Yoshimura H
    Biol Pharm Bull; 1993 Oct; 16(10):1008-13. PubMed ID: 8287029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The potentiation of barbiturate-induced narcosis by procarbazine.
    Lee IP; Lucier GW
    J Pharmacol Exp Ther; 1976 Mar; 196(3):586-93. PubMed ID: 1263114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gonadal hormone modulation of ∆
    Craft RM; Haas AE; Wiley JL; Yu Z; Clowers BH
    Pharmacol Biochem Behav; 2017 Jan; 152():36-43. PubMed ID: 27670094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of oestrogens and progestins on the response of mice to barbiturates.
    Blackham A; Spencer PS
    Br J Pharmacol; 1969 Sep; 37(1):129-39. PubMed ID: 5360338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analgesic interaction between nitrous oxide and delta-9-tetrahydrocannabinol in the rat.
    Novelli GP; Peduto VA; Bertol E; Mari F; Pieraccioli E
    Br J Anaesth; 1983 Oct; 55(10):997-1000. PubMed ID: 6313026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancement by alpha-fluoromethylhistidine of the thiopental sleep-prolonging action of delta 9-tetrahydrocannabinol.
    Oishi R; Itoh Y; Nishibori M; Saeki K; Ueki S
    Psychopharmacology (Berl); 1988; 95(1):77-81. PubMed ID: 2838862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolongation of barbiturate-induced sleeping time in mice by dimethylformamide (DMF) and other non-polar solvents: absence of an effect on hepatic barbiturate-metabolising enzymes.
    Weetman DF; Crossfield C
    Methods Find Exp Clin Pharmacol; 1982; 4(2):99-103. PubMed ID: 7121125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neutralization of the effect of delta 9-tetrahydrocannabinol on barbiturate sleeping time by specific active immunization.
    Giusti GV; Chiarotti M; Vigevani F
    Drug Alcohol Depend; 1980 Mar; 5(3):185-7. PubMed ID: 6243536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cellular immune function in mice tolerant to or abstinent from l-trans-delta 9-tetrahydrocannabinol.
    Bhargava HN; House RV; Thorat SN; Thomas PT
    Pharmacology; 1996 May; 52(5):271-82. PubMed ID: 8807671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analgesic activity of 9 -tetrahydrocannabinol in the rat and mouse.
    Buxbaum DM
    Psychopharmacologia; 1972; 25(3):275-80. PubMed ID: 5044401
    [No Abstract]   [Full Text] [Related]  

  • 14. Depressant effect of delta-1-tetrahydrocannabinol enhanced by inhibition of its metabolism.
    Sofia RD; Barry H
    Eur J Pharmacol; 1970; 13(1):134-7. PubMed ID: 5496922
    [No Abstract]   [Full Text] [Related]  

  • 15. Perinatal exposure to delta 9-tetrahydrocannabinol (delta 9-THC) leads to changes in opioid-related behavioral patterns in rats.
    Vela G; Fuentes JA; Bonnin A; Fernández-Ruiz J; Ruiz-Gayo M
    Brain Res; 1995 May; 680(1-2):142-7. PubMed ID: 7663970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative analgesic activity of various naturally occurring cannabinoids in mice and rats.
    Sofia RD; Vassar HB; Knobloch LC
    Psychopharmacologia; 1975; 40(4):285-95. PubMed ID: 1170585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of caffeine on barbiturate sleeping time and brain level.
    Aeschbacher HU; Atkinson J; Domahidy B
    J Pharmacol Exp Ther; 1975 Mar; 192(3):635-41. PubMed ID: 1120961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of barbiturates in rats tolerant to delta 9-tetrahydrocannabinol.
    McMillan DE; Hardwick WC; Wells JD
    Arch Int Pharmacodyn Ther; 1983 Jul; 264(1):4-14. PubMed ID: 6312913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Study of the analgesic effects of galanthamine, a cholinesterase inhibitor.
    Cozanitis DA; Friedmann T; Fürst S
    Arch Int Pharmacodyn Ther; 1983 Dec; 266(2):229-38. PubMed ID: 6667067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opiate properties of SKF 525A.
    Ho TK; LaBella FS; Pinsky C
    Can J Physiol Pharmacol; 1978 Aug; 56(4):550-4. PubMed ID: 210915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.